close

For more than four decades, Fenwick & West LLP has helped some of the world’s most recognized companies become, and remain, market leaders. From emerging enterprises to large public corporations, our clients are leaders in the technology, life sciences and cleantech sectors and are fundamentally changing the world through rapid innovation.  MORE >

Fenwick & West was founded in 1972 in the heart of Silicon Valley—before “Silicon Valley” existed—by four visionary lawyers who left a top-tier New York law firm to pursue their shared belief that technology would revolutionize the business world and to pioneer the legal work for those technological innovations. In order to be most effective, they decided they needed to move to a location close to primary research and technology development. These four attorneys opened their first office in downtown Palo Alto, and Fenwick became one of the first technology law firms in the world.  MORE >

From our founding in 1972, Fenwick has been committed to promoting diversity and inclusion both within our firm and throughout the legal profession. For almost four decades, the firm has actively promoted an open and inclusive work environment and committed significant resources towards improving our diversity efforts at every level.  MORE >

At Fenwick, we are proud of our commitment to the community and to our culture of making a difference in the lives of individuals and organizations in the communities where we live and work. We recognize that providing legal services is not only an essential part of our professional responsibility, but also an excellent opportunity for our attorneys to gain valuable practical experience, learn new areas of the law and contribute to the community.  MORE >

Year after year, Fenwick & West is honored for excellence in the legal profession. Many of our attorneys are recognized as leaders in their respective fields, and our Corporate, Tax, Litigation and Intellectual Property Practice Groups consistently receive top national and international rankings, including:

  • Named Technology Group of the Year by Law360
  • Ranked #1 in the Americas for number of technology deals in 2015 by Mergermarket
  • Nearly 20 percent of Fenwick partners are ranked by Chambers
  • Consistently ranked among the top 10 law firms in the U.S. for diversity
  • Recognized as having top mentoring and pro bono programs by Euromoney

MORE >

We take sustainability very seriously at Fenwick. Like many of our clients, we are adopting policies that reduce consumption and waste, and improve efficiency. By using technologies developed by a number of our cleantech clients, we are at the forefront of implementing sustainable policies and practices that minimize environmental impact. In fact, Fenwick has earned recognition in several areas as one of the top US law firms for implementing sustainable business practices.  MORE >

At Fenwick, we have a passion for excellence and innovation that mirrors our client base. Our firm is making revolutionary changes to the practice of law through substantial investments in proprietary technology tools and processes—allowing us to deliver best-in-class legal services more effectively.   MORE >

Mountain View Office
Silicon Valley Center
801 California Street
Mountain View, CA 94041
650.988.8500

San Francisco Office
555 California Street
13th Floor
San Francisco, CA 94104
415.875.2300

Seattle Office
1191 Second Avenue
10th Floor
Seattle, WA 98101
206.389.4510

New York Office
1211 Avenue of the Americas
32nd Floor
New York, NY 10036
212.921.2001

Shanghai Office
Unit 908, 9/F, Kerry Parkside Office
No. 1155 Fang Dian Road
Pudong New Area, Shanghai 201204
P.R. China
+86 21 8017 1200


Life Sciences, Tech IPOs Soared In 2013

April 24, 2014

​Partners Dan Winnike and Jeff Vetter are quoted in a Law360 article on their biannual IPO Survey, which found a a 62 percent year-over-year increase in initial public offerings by life sciences and technology companies.

A total of 78 life science and technology companies conducted an IPO in 2013, compared to just 49 in 2012, the Fenwick co-authors found, suggesting substantial investor confidence in those sectors. 

The growing popularity of IPOs was likely due to investors’ increasing willingness to back new medical devices and products, Winnike told Law360.

“Life science companies are usually pretty capital-hungry in the early stages of development, before they bring their medical devices or products to market and start making any revenue,” he said. “When those businesses see that the market is receptive, they are more likely to start gearing up for an IPO.”

The number of IPOs for life sciences companies jumped from 14 in 2012 to 41 in 2013, the Fenwick survey found. In the second half of 2013, 61 percent of life sciences IPOs raised more than $75 million and 83 percent saw their shares trading above their designated price range.

Vetter said that the IPO market for life sciences and technology companies has been choppy in the early part of 2014, but he expects it to pick back up in the second half of the year.

"What everyone is wondering now is whether the bloom is off the rose," Vetter said. "Though that seems a bit short-sighted, especially coming off of such a strong close to 2013 when the speed with which IPOs were getting done and the number of new issuers coming back to market with follow-ons demonstrated an unusually robust appetite for new offerings. We'd like to see the same second-half trend in 2014."

The survey found that a record eight technology companies and three life sciences companies that completed IPOs in the second half of 2013 also completed a follow-on offering within six months.

The full article is available through the Law360 website (subscription required).